Clinical trial
Assessing Breast and Cervical Cancer Stigma and Piloting a Mitigating Intervention in Rwanda
NCT07663006 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing Breast and Cervical Cancer Stigma and Piloting a Mitigating Intervention in Rwanda
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- December 1, 2029
- Enrollment
- 1,116 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, cervical cancer